Document is current
Any future updates will be listed below
-
Authors
Xu, Xiangyanyu
Wu, Yanpeng
Kummer, Allisandra G.
Zhao, Yuchen
Hu, Zexin
Wang, Yan
Liu, Hengcong
Ajelli, Marco
Yu, Hongjie
-
Funding
Funding for this research was provided by:
the Key Program of the National Natural Science Foundation of China (82130093)
Shanghai Municipal Science and Technology Major Project (HS2021SHZX001)
the Centers for Disease Control and Prevention and the Council of State and Territorial Epidemiologists (NU38OT000297)
- License Information
-
More Information
Article History
Received: 17 May 2023
Accepted: 5 September 2023
First Online: 29 September 2023
Declarations
:
: Not applicable.
: Not applicable.
: HY has received research funding from Sanofi Pasteur, GlaxoSmithKline, Yichang HEC Changjiang Pharmaceutical Company, Shanghai Roche Pharmaceutical Company, and SINOVAC Biotech Ltd. MA has received research funding from Seqirus. None of those funding is related to this research. All other authors report no competing interests.
